We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vistin Pharma Asa | LSE:0RAM | London | Ordinary Share | NO0010734122 | VISTIN PHARMA ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.25 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 438.33M | 45.6M | 1.0282 | 10.94 | 498.88M |
Saga Pure ASA has on 13 September 2024 purchased 250,000 shares in Vistin Pharma ASA at NOK 25.13 per share. After the transaction Saga Pure ASA has a holding of 650,000 shares, corresponding to 1.47% ownership. Saga Pure ASA is closely associated with board member Øystein Stray Spetalen.
After the transaction Øystein Stray Spetalen and associated companies will have a total holding of 2,224,401 shares, corresponding to 5.02 % ownership.
Attachment
1 Year Vistin Pharma Asa Chart |
1 Month Vistin Pharma Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions